Please login to the form below
Eladynos
This page shows the latest Eladynos news and features for those working in and with pharma, biotech and healthcare.
ViiV’s two-drug HIV combo backed by CHMP
There was bad news for three other companies, with the CHMP issuing negative opinions for Portola’s Dexxience (betrixaban) for the prevention of venous thromboembolism, Radius International’s osteoporosis candidate Eladynos
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Great salary and bebefits
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Project Manager, Medical Communications, London
-
Excellent Salary
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Senior Account Director, Healthcare Brand Communications, London
-
Excellent Package
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Medical Writer, e-learning/ training, London
-
Excellent Salary
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
-
Scientific Director
-
Great salary and bebefits
- Editor – Medical Education Agency – Bucks
-
Salary TBC
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Project Manager, Medical Communications, Oxford
-
Excellent Salary
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
Subscribe to our email news alerts
- VCCP health strengthens client service team
- Is agile working benefiting the employee or the organisation?
- Putting the patient first
- The threat of antimicrobial resistance
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Wordbird strikes CPD gold in their first year of IPA membership – the only agency to achieve this accolade this year
Latest intelligence
- The threat of antimicrobial resistance
- Why this issue is such a fundamental challenge...
- Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
- Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
- Unique forum will unite NHS and industry to drive innovation
- HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...
Quick links
Infographics
